DCOY
Decoy Therapeutics Inc.
NASDAQHealthcareBiotechnologyUS
Rating:C+
Company Profile
CEO
Frederick E. Pierce
IPO Date
2015-01-29
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Decoy Therapeutics Inc.
CEO
Frederick E. Pierce
IPO Date
2015-01-29
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
| $0.64 |
| 24 Nov 2025 | HANISH ARNOLD C | director | P-Purchase | Acquired | 5,000 | $0.75 |
| 24 Nov 2025 | Marschel Peter Klaus | Chief Business Officer | Disposed | 50,619 | $0.00 |
| 24 Nov 2025 | Marschel Peter Klaus | Chief Business Officer | Disposed | 5,061 | $4.94 |
| 24 Nov 2025 | Marschel Peter Klaus | Chief Business Officer | Disposed | 8,318 | $50.26 |
| 24 Nov 2025 | Hibner Barbara Louise | Chief Scientific Officer | Disposed | 50.619 | $0.00 |
| 24 Nov 2025 | Hibner Barbara Louise | Chief Scientific Officer | Disposed | 5,061 | $4.94 |
| 24 Nov 2025 | Hibner Barbara Louise | Chief Scientific Officer | Disposed | 8,318 | $50.26 |
| 24 Nov 2025 | PIERCE FREDERICK II | Chief Executive Office | Disposed | 0 | $0.00 |